نتایج جستجو برای: myeloproliferative neoplasms

تعداد نتایج: 500280  

Journal: :American Journal of Clinical Pathology 2015

Journal: :European journal of haematology 2015
Stephen E Langabeer Hajnalka Andrikovics Julia Asp Beatriz Bellosillo Serge Carillo Karl Haslam Lasse Kjaer Eric Lippert Olivier Mansier Elisabeth Oppliger Leibundgut Melanie J Percy Naomi Porret Lars Palmqvist Jiri Schwarz Mary F McMullin Susanne Schnittger Niels Pallisgaard Sylvie Hermouet

Since the discovery of the JAK2 V617F mutation in the majority of the myeloproliferative neoplasms (MPN) of polycythemia vera, essential thrombocythemia and primary myelofibrosis ten years ago, further MPN-specific mutational events, notably in JAK2 exon 12, MPL exon 10 and CALR exon 9 have been identified. These discoveries have been rapidly incorporated into evolving molecular diagnostic algo...

2014
Noa Lavi

With the discovery of the JAK2V617F mutation in patients with Philadelphia chromosome-negative (Ph(-)) myeloproliferative neoplasms (MPNs) in 2005, major advances have been made in the diagnosis of MPNs, in understanding of their pathogenesis involving the JAK/STAT pathway, and finally in the development of novel therapies targeting this pathway. Nevertheless, it remains unknown which mutations...

2010
Vittorio Rosti Elisa Bonetti Gaetano Bergamaschi Rita Campanelli Paola Guglielmelli Marcello Maestri Umberto Magrini Margherita Massa Carmine Tinelli Gianluca Viarengo Laura Villani Massimo Primignani Alessandro M. Vannucchi Francesco Frassoni Giovanni Barosi

Increased mobilization of circulating endothelial progenitor cells may represent a new biological hallmark of myeloproliferative neoplasms. We measured circulating endothelial colony forming cells (ECFCs) in 106 patients with primary myelofibrosis, fibrotic stage, 49 with prefibrotic myelofibrosis, 59 with essential thrombocythemia or polycythemia vera, and 43 normal controls. Levels of ECFC fr...

Journal: :American Journal of Clinical Pathology 2016

2013
Ahmet Burak Toros Serkan Gokcay Guven Cetin Muhlis Cem Ar Yesim Karagoz Besir Kesici

Background/Objectives. Patients with myeloproliferative neoplasms have a well-established increased risk of thrombosis. Many trials report identification of an underlying myeloproliferative neoplasm by investigation of the patients developing portal hypertensive esophagus and/or fundus variceal hemorrhage in the absence of any known etiology. This trial was designed to investigate the associati...

2016
A. ILEA A. M. VLĂDĂREANU

This article reports the molecular diagnosis findings regarding chronic myeloproliferative neoplasms made in a Molecular Biology Laboratory over a seven years’ experience (between 2009 and 2015). Ritus Biotec ltd is an ELN (European Leukemia Net) certified diagnostic laboratory for quantification of BCR-ABL. 1373 patients were subjected to Jak2 V617F testing in this time frame. The patients wer...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید